Background: Dravet Syndrome (DS) is a rare developmental and epileptic encephalopathy characterized by multiple seizures, frequently prolonged and treatment refractory, with significant developmental disabilities and behavioral and psychiatric disorders. Patients with DS require intensive support and supervision from a caregiver, impacting significantly on both patients' and caregivers' lives. This study aimed to identify core concepts to measure the impact on both patients and caregivers in future DS clinical trials. Methods: Qualitative concept elicitation interviews were conducted with caregivers and healthcare professionals involved in caring for children with DS (aged 2-18 years) in France to identify important concepts related to the global impact of DS. Interviews explored a range of concepts, including triggers, symptoms, impacts, and coping strategies, from which a conceptual model was developed. A Delphi consensus panel with eight international clinical experts aimed to identify important and relevant endpoints. Results: Seizure was the most commonly reported symptom with DS further impacting children's cognitive and behavioral functioning. Caregivers identified impact concepts not reported by healthcare professionals. Both groups described additional impacts on wider family members and home modifications. Clinical experts agreed on the inclusion of five patient-and caregiver-relevant concepts for measurement in future DS clinical trials in a composite endpoint. The five concepts for inclusion were; seizures, expressive communication of the child, receptive communication of the child, impact on daily activities, and social functioning of the caregiver. Conclusions: This study showed the wider potential impact of DS to extend beyond that of seizures, demonstrating that there is a need for additional patient-and caregiver-relevant concepts to be measured in clinical trials to fully identify the value of therapeutic interventions.
Introduction
Dravet Syndrome (DS) is a rare therapy-resistant epilepsy syndrome [1] which is associated with a sodium channel SCN1A gene de novo mutation in most cases [2, 3] . Although global incidence of DS is unknown, in 1990 it was estimated as 1 per 40,000 children before the age of seven in the US [4, 5] ; more recently, the incidence in the US was estimated to be 1 per 15,700 [1] . Dravet Syndrome is pharmacoresistant, with a significant unmet need for an efficacious treatment, similar to Lennox-Gastaut Syndrome [6] and Infantile Spasms/West's Syndrome [7] ; however, DS has a more homogenous presentation regarding seizure experienced and etiology [8, 9] . The condition is an example of a rare developmental epileptic encephalopathy characterized by severe and frequent seizures that have significant negative impacts on cognitive and behavioral functioning, and the health-related quality of life (HRQoL) of patients and the quality of life (QoL) of their caregivers.
Dravet Syndrome typically presents in the first year of life with prolonged, febrile and afebrile, generalized clonic or hemiclonic seizures in previously healthy infants [4, 10] . Other seizure types, including myoclonic, focal and atypical absence, which usually appear between 1 and 4 years [10] . Initial convulsive seizures are often prolonged and fever-sensitive; other types of seizures including generalized and multifocal usually emerge by the second year of life [10] . Although progression varies, seizures can be life-threatening with frequent status epilepticus [10] .
Children with DS experience significant developmental delay and psychosocial problems. These problems are particularly apparent in the second to fourth years of life, with symptoms becoming milder with increasing age but still significantly impairing patients' HRQoL [2] . The immediate, short-and long-term cognitive, behavioral, and social sequelae of DS require extensive care from caregivers and sustained medical support [2, 4, [10] [11] [12] . Physically, patients experience fine and gross motor skill impairments, ataxia and gait disturbances [10, 13] . The agglomeration of these impairments can have a significant impact on the HRQoL of children diagnosed with DS.
Antiepileptic drug (AED) combinations control certain seizures or decrease the frequency of status epilepticus and might contribute to improvement in some aspects of cognitive and behavioral function [9, 14] . However, current treatments are noncurative and certain seizures remain pharmacoresistant during childhood and adolescence [9, 15] . Importantly, patients taking AEDs may experience tolerability issues and adverse events including cognitive impairment, fatigue, reduced appetite, insomnia, and aggressive behavior [9, 15, 16] . These treatment complications may require frequent hospital admissions [17] and have a detrimental impact not only on the patient but also their caregiver [18] . Thus, there is an unmet need for an efficacious DS treatment to control seizures and increase the HRQoL of patients with DS and the QoL of caregivers.
The quantity and quality of caregiver support required by a child with DS can be emotionally and financially challenging [19] . Research in caregiver support is increasing for this rare disease [12, 15, 17, [19] [20] [21] . For example, Skluzacek et al. investigated the use of parent support networks to reduce caregiver burden of DS [20] . Caregivers (n = 833 in 46 countries) completed a survey assessing child and caregiver impacts, including sleep disturbance, adaptation, distress, and increasing the understanding of the DS experience. This survey provided additional insights into DS; however, the survey used predefined questions, therefore, spontaneous reporting from participants was not possible. Therefore, it is possible that not all patient-relevant and caregiver-reported concepts were captured. Additionally, the methodological approach used in the development of the survey was not described; therefore, the rationale for the inclusion of questions and the content validity of the measure cannot be fully assessed.
Other studies have been conducted in DS using a more qualitative methodology to understand better the impacts of DS [19, 21] . In both studies, by Nolan et al. and Camfield et al., the researchers interviewed families and developed various coping strategies to enable families to function better and more prepared for the impacts associated with the disease. The authors comment that the articles are of practical use for families impacted by DS, which is invaluable. However, there was no clear description of the approach taken to developing a consensus on patient-and caregiver-relevant impacts, nor how these could be better measured to assess the usefulness of interventions. In order to assess treatment benefits of new drugs or interventions, it is important to identify the concepts of greatest interest, i.e., those impacts which have the greatest effect on the patient and caregivers.
Assessing both seizure efficacy and the wider impact on patient HRQoL and caregiver QoL, is essential to understand the global impact of DS. Having a greater understanding of the global impact of DS on the patient and caregiver would facilitate the development of a core set of outcome measures which in turn, could be included in a composite clinical endpoint. Researchers could use this composite endpoint in DS clinical trials, regardless of the intervention, to capture the wider impact of interventions on patients and caregivers, rather than focus specifically on seizure reduction.
This study aimed to identify a core set of patient-and caregiverrelevant concepts that would be suitable to include in a DS clinical trial to provide the basis for future development of a composite endpoint for DS. This study progressed in three stages. The first stage was to explore the global impact of DS by conducting qualitative interviews with caregivers and healthcare professionals involved in the care of children with DS. The outputs of these interviews were used to develop a conceptual model that captures the core concepts relevant to DS. The second stage involved using a modified Delphi consensus panel with international clinical experts to identify the concepts within the DS conceptual model for which a treatment effect could reasonably be expected. The Delphi consensus panel ranked concepts in order of perceived clinical relevance while being mindful of those concepts that would likely improve with successful treatment. Finally, these core concepts were mapped onto existing instruments to identify relevant outcome measures (and endpoints) that could be used to comprehensively assess the most important patient with DS and caregiver-relevant concepts.
Material and methods

Study design
As the nature of the research question was to explore patient-and caregiver-relevant concepts related to the impact of DS, this study employed an inductive qualitative methodology. Participants (caregivers and healthcare professionals) involved in the care of children with DS (aged 2-18 years old) in France were recruited to take part in a qualitative concept elicitation interview, to elicit spontaneous reports about their experience of DS. A semi-structured interview guide was developed, following a review of published literature on DS and similar developmental epileptic encephalopathies. Clinical experts reviewed and provided input during the development of the interview guide, drawing from their expert knowledge of the condition and ensuring the content was clinically relevant. Generic HRQoL questions, which apply to any health condition, were also used in the interview guide. Concepts identified from these interviews were then ranked in order of importance by clinical experts using a modified version of the Delphi consensus panel [22] .
Sample
Participants (caregivers and healthcare professionals) involved in the care of children with DS (aged 2-18 years old) were targeted for recruitment. International clinical experts were also targeted to participate in the modified Delphi consensus panel. Healthcare professionals recruited for the qualitative interviews and the clinical experts used in the Delphi consensus panel were independent. To avoid bias, healthcare professionals who were interviewed as part of the study did not contribute to any other part of the study, while the clinical experts who were involved in the study design and execution were not interviewed as study participants.
Recruitment
Clinical experts, at two separate clinical sites in France, identified caregivers who met the inclusion criteria to participate in the study. These caregivers were invited to attend an in-person interview at the clinical site, or to participate in a telephone appointment, if more convenient. The inclusion and exclusion criteria for caregivers and healthcare professionals are outlined in Table 1 .
Clinical experts confirmed eligibility of caregivers and diagnosis of their child with DS. Written informed consent was obtained and demographic information collected from all participants. Recruitment quotas ensured that participants recruited included a diverse range of demographic characteristics (e.g., gender and age of individual, caregiver gender). Prior to initiating research activities, the study was granted a waiver in France from the National Board of Physicians (reference: DO151123) and Nurses (reference: DO151125).
Data collection
Qualitative concept elicitation interviews were conducted with caregivers and healthcare professionals, to elicit spontaneous reports about their experience of DS. All interviews were conducted by telephone in French by trained native language researchers following the semi-structured interview guide, using open-ended questioning designed to elicit spontaneous information from participants. This ensured that participants discussed concepts most important to their experience. Participants were then asked more focused questioning designed to probe issues not previously mentioned. For example, if participants had not spontaneously mentioned key symptoms or child and caregiver impacts. All interviews lasted up to an hour, were digitally recorded and transcribed verbatim.
Scientific terms of key concepts (for example, anorexia and somnolence) were not used during the interviews, unless participants used these terms spontaneously.
More general and open-ended questions relating to these concepts were used, to ensure that the participant fully understood what was being asked and to minimize probing questions. The semi-structured interview guide used in these interviews is included as supplementary material.
Analysis
Interview transcripts were translated into English prior to qualitative analysis, whereby quotes were sorted into concepts using methods derived from thematic analysis [23] . Analysis was performed using Atlas.ti computerized software, which facilitates the breakdown of qualitative data into groups [24] . An inductive analysis approach was adopted whereby all themes identified were driven by data rather than defined a-priori. A coding tree was developed prior to analysis of any interviews to structure how concepts and subconcepts would be coded. The coding tree was used consistently to guide coding of all interviews ( Fig. 1) . A team of experienced qualitative researchers coded the transcripts in parallel using a constant comparative method to ensure that codes were consistently applied [25] . Following analysis of interviews, a preliminary conceptual model was drafted based on caregiver and clinician interviews, including identified symptom, trigger, child and caregiver impacts, and coping strategies.
Conceptual saturation was assessed to establish whether the sample size of caregivers and healthcare professionals was large enough to be considered representative. Conceptual saturation is defined as the point at which no new concepts emerge with conduct of additional interviews [26] . If conceptual saturation is achieved, this implies that there is confidence that the research question has been fully answered. Conceptual saturation can be achieved in as few as 12 participants [27] . Analysis was conducted in the overall sample and then in each participant group separately (caregivers and healthcare professionals). The overall sample was split into approximately three even-sized groups based on the order interviews were conducted. To achieve conceptual saturation and to be confident that all patient-and caregiver-relevant concepts had been elicited, all concepts should be elicited in the first or second groups. If new concepts emerged in the third group, this indicated that the sample size was not adequate and there is a risk that additional findings would emerge with the conduct of further interviews. Conceptual saturation tables were developed to assess saturation of concepts.
Following analyses of the qualitative interviews, a Delphi consensus panel was conducted with international clinical experts in DS [22] (please see Acknowledgments for details of the clinical experts) to identify what they considered to be the most important patient-and caregiver-relevant concepts, and therefore reduce the concepts down to a core set, which would potentially be amenable to a therapeutic intervention. Clinical experts were chosen for inclusion in the modified Delphi consensus panel because they were considered the most appropriate participant group to identify clinically relevant concepts to be included in the composite endpoint for which a treatment effect could be expected. Techniques such as Delphi consensus panels are widely accepted methods in medical and health research to gain consensus on topics often where there are gaps or unclear guidelines [22, [28] [29] [30] . Specifically, the technique has been successfully applied to develop international clinical practice guidelines for the treatment of conditions associated with epilepsy [31] . Clinical experts were initially asked to rate the main concepts elicited from the qualitative interviews in order of importance with a score of '0' meaning not at all important and 100 meaning very important. Responses were then collated, summarized, and the number of concepts reduced, by retaining the highest rated concepts only. A minimum threshold of 78 (upper quartile threshold) was used to indicate which concepts were important as rated by a large proportion of the clinical experts, and retained for the second round of the Delphi consensus panel. For the second round, clinical experts were again asked to provide rating scores for each concept retained and to rank all concepts by importance, from 1 to 11 with 1 indicating the most important concept and 11, the least. Results were then analyzed, and the number of concepts reduced further by retaining the highest ranked concepts by a large proportion of clinical experts using an inclusion threshold of 80 for the average rating score, based again on concepts ranked in the upper quartile threshold.
Results
Demographic characteristics
In total, 11 participants were recruited to participate in this study. Caregivers (n = 7; male = 4, female = 3) had a mean age of 40.7 years (Table 2) , caring for mostly male (male = 5, female = 2) children with DS, with a mean age of 15 months at diagnosis. More children with DS (42.9%) were aged 5-8 years, with fewer aged 9-11 years and 
Concept elicitation findings
The predominant symptom/sign of DS reported was seizures, which was elicited by all participants (n = 11). Seizure types included generalized (n = 10), convulsive (n = 8), absence (n = 7), tonic-clonic (n = 6), and myoclonic and focal/partial (n = 5, respectively). Seizures were reported to last between 5 s and several hours. Seizure frequency was reported as variable, and seizures were reported as occurring in a series with seizure-free intervals between them. A range of seizure signs were also reported, including jumps/jerks, blinking eyes, loss of consciousness (n = 2, respectively), and tremors (n = 1). Participants reported a number of triggers, the most common included; fevers (n = 11), changes in external temperature (n = 9), submersion in water (n = 7), excitement (n = 5), and illness/infection (n = 5).
"We don't let her to get too excited… It happens, it is a trigger for the seizures, we know it."
[(Participant 8)]
"These kids, the minute they have a fever, when their temperature rises, they have a seizure."
Throughout these interviews, differences were identified in the types of seizures reported by age of the child or severity of the child's condition. Specifically, younger children with DS (aged 5-8 years at the time of interview) commonly experienced convulsive, focal/partial, and tonic-clonic seizures (n = 2, respectively). Children aged 9-11 years experienced myoclonic and absence seizures (n = 1, respectively), while children aged 12-18 years old most commonly experienced generalized and convulsive seizures (n = 2, respectively).
In addition to seizures, numerous impacts on children with DS were identified from the interviews (Fig. 2 ). This included: cognitive functioning (e.g., learning, attention (n = 10, respectively), expressive communication (n = 9), receptive communication, emotional experience (n = 7, respectively)), motor skills (e.g., gross motor function (n = 11) and fine motor function (n = 8)), and behavioral functioning (e.g., general behavior, anorexia (n = 10, respectively) and emotional expression (n = 4)).
"She has trouble speaking, she doesn't talk like you and me, she has trouble articulating and she is constantly finding her words. She has a restricting vocabulary …she doesn't speak correctly, and we have to figure out what she is trying to say."
[(Participant 6)]
"He suffers from a certain ataxia, he walks with his knees in the inside, his feet, so he has a particular walk, he doesn't have a good balance."
Participants reported a range of impacts on caregivers, grouped into the broad domains of: daily activities, work, family, leisure activities (n = 9, respectively), emotional (n = 8), sleep (n = 7), financial (n = 6), social and physical (n = 5, respectively; Fig. 3 ). Participants mentioned a range of coping strategies to help patients and their caregivers manage DS. Most frequently reported were; home adjustments (n = 7), use of assistive aid/devices (n = 6), coping strategies relating to daily activities (n = 5), preventative behaviors (n = 3), and communication (n = 1). No apparent differences were identified in the type of impacts reported by child age or severity of child's condition. Additionally, no differences in findings were identified by other demographic characteristics including gender or age of the caregiver.
Conceptual model
A conceptual model was developed based on the interview-elicited concepts, representing all the symptom/sign, trigger, impact, and coping strategy concepts (Fig. 4) . The model depicts each of these relevant concepts and their interrelationships, providing an overview of the broad experience of DS reported by caregivers and healthcare professionals. Notably, a wide range of concepts were elicited only by caregivers and not reported by healthcare professionals, highlighting the value of the caregiver perspective in identifying the core set of patient-and caregiver-relevant endpoints. These included child-related concepts of anorexia (defined as the general loss of appetite or interest in food), somnolence, social functioning, expressive communication, and behavior. Concepts predominantly mentioned by caregivers included: seizure management, coping strategies relating to daily activities, use of assistive aids, preventative behaviors, and home adjustments. It is worth noting, however, that a range of caregiver impacts were elicited by both caregivers and healthcare professionals including those impacting on daily activities, leisure activities, family, and finances.
Conceptual saturation
Conceptual saturation was continually assessed during the interviews (Table 3 ). The overall sample was split into three groups with all core domains considered saturated if they were elicited in the first or second group of participants. All core symptom/sign and impact concepts were elicited in the first group, indicating that conceptual saturation had been achieved and the size of the overall sample was sufficient. Conceptual saturation was also assessed for each participant group (healthcare professionals and caregivers) separately. All core symptom/sign and impact concepts were elicited in the first and second groups, indicating that the sample size for each participant group was sufficient and that no new concepts would emerge by conducting additional interviews.
Delphi consensus panel technique
A Delphi consensus panel was conducted with eight international expert DS clinicians in round one and seven in round two. In round one, seizures were the most important patient-relevant concept, while impact on families was the most important to caregivers (Table 4) . Using the prespecified criteria for inclusion detailed in the methods, the number of concepts was reduced from 17 to 10. Of note, sleep disturbance should have been excluded according to these prespecified criteria; however, prior qualitative interviews with caregivers highlighted this as an important concept. Therefore, it was retained for round two of the Delphi consensus panel.
In the second round of the Delphi consensus panel, seizure was again rated and ranked the highest patient-relevant concept, while impact on daily activities was the highest caregiver-relevant concept (Table 5) . Notably, the top five concepts were the same using both the rating and ranking techniques, confirming the final list of concepts to be measured.
Identification of the core set of endpoints for inclusion in the DS trial
The concepts identified following the qualitative interviews and agreed on by international experts in a Delphi consensus panel, were mapped to instruments for inclusion in a multinational randomized placebo controlled trial in DS. These five concepts, both patient-and caregiver-relevant concepts were selected based on clinical relevance and for which a treatment effect could reasonably be expected. Identified concepts included seizures, cognitive functioning, behavioral functioning, impacts on child (i.e., somnolence, sleep disturbance, physical, social and school functioning), and impact on caregiver QoL. The concepts to be considered for inclusion in a composite endpoint were mapped onto existing instruments, to determine the conceptual coverage of the instruments. This process involved comparing the interview-identified concepts with the concepts measured in each instrument. The following instruments, which have been used in DS clinical trials, were identified for the conceptual mapping exercise: Pediatric Quality-of-Life Inventory (PedsQL) [32] , Behavior Rating Inventory of Executive Function (BRIEF-P) [33] , Quality of Life in Childhood Epilepsy Scale (QOLCE) [34] , Karolinska Sleepiness Scale [35] , Pediatric Quality-of-Life Inventory-Family Impact Module (PedsQL-FIM) [36] , and EuroQoL Five Dimension Five Level (EQ-5D-5L) [37] . The results of this mapping exercise indicated that each of the identified instruments provides a comprehensive coverage of the important concepts for inclusion in DS clinical trials.
Discussion
This paper describes the methods and results of eliciting patientand caregiver-relevant concepts in DS using in-depth qualitative interviews with caregivers and healthcare professionals and of a Delphi consensus panel with international clinical experts involved in the care of children with DS. The purpose of this research was to identify a core Table 3 Conceptual saturation analysis of caregiver, child, and symptom concepts elicited in the interviews.
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Daily set of concepts for potential inclusion in a composite endpoint which could be used in clinical trials to capture meaningful change from the patient and caregiver perspective. As a requirement for inclusion, these concepts had to be clinically meaningful and have the potential to be measured and change over time with treatment. Consistent with previous research in this area [4] , seizure was the most common symptom/sign reported among participants. Even from the small sample size, we were able to identify differences in the types of seizures experienced by age group of child, with younger children (5-8 years) more commonly experiencing convulsive, focal and tonicclonic seizures, and older children (9-18 years) experiencing myoclonic, absence, generalized, and convulsive seizures more frequently. This is broadly consistent with the published literature, whereby seizures vary considerably by age of child, with less severe seizures occurring as the child gets older [2, 38] .
During the research process, participants elicited numerous seizure triggers. These included fever, external temperature changes, and emotional excitement. Other triggers were reported, such as swimming or social events; however, it is likely that the seizures were initiated by emotional and metabolic factors [39] associated with these events rather than the events per se. In addition to seizures, an extensive range of cognitive and behavioral impacts on children with DS were also reported. A notable finding of the interviews was the wider impact on caregivers, most commonly affecting daily activities, work, family, relationships, and leisure activities. Children with DS require demanding and constant support, which presents a substantial burden on caregivers.
Many caregivers reported using coping strategies to ameliorate their caregiving burden; mostly through making home adjustments and making use of assistive aids or devices. Mostly caregivers reported such strategies, together with additional child impact subconcepts. Coping strategies used by caregivers and many child impact subconcepts were not reported by as many healthcare professionals. This may suggest that caregivers do not discuss the wider impacts of DS with their clinicians, their interactions being more focused on discussing seizures impact and therapies.
In summary, these qualitative interview findings highlight that the global impact of DS on both patients and their caregivers extends beyond the effect of seizures alone. This is consistent with previous literature in general epilepsy, which identifies multiple impacts on many domains of patient's and caregiver's lives, supporting a biopsychosocial approach to treatment [40] .
In two rounds of the Delphi consensus panel, five core concepts were agreed by the clinical experts as important, for inclusion as 'core' outcome measures in clinical trials of DS. The selection of these five core concepts were identified using a prespecified thresholds for each stage of the Delphi consensus panel. The thresholds were set to reduce the large list of concepts and minimize the burden associated with completing the measure in a clinical trial setting. The methodology used to reduce the number of concepts also ensured that the most clinically important concepts, which were sensitive to change to indicate a treatment benefit, were included. It is possible that a larger number of concepts could have been included in the final core set, for example by including patients in the Delphi panel. However, the final outcome measure would be considerably longer, more burdensome for caregivers to complete, and compliance in completing the measures would likely be reduced. This would result in a large number of missing data and therefore, jeopardizing the reliability of the results obtained from The results from both the qualitative interviews with caregivers and healthcare professionals and the Delphi consensus panel of clinical experts confirm the content validity of the patient-and caregiverrelevant concepts. Six validated instruments were identified for assessment of these concepts (and endpoints). Each provided good conceptual coverage and was thus considered appropriate to comprehensively assess DS, from both the patient and caregiver perspectives.
A key strength of the study was that both caregivers and healthcare professionals were interviewed, enabling comparisons between the two groups, and importantly highlighting the value of the caregiver experience and perspective. Validation of interview-identified concepts with the Delphi consensus panel of international clinical experts confirmed the clinical importance of measuring such concepts in DS clinical trials. The Delphi consensus panel allowed knowledge gathering from clinical experts who were spread geographically but able to participate remotely. This consensus methodology is also beneficial when little research-based evidence exists, enabling decision-making based on clinical expertise and experience. Thus, it may be particularly useful in rare diseases as in the case with DS [41] . Additionally, the Delphi consensus panel allows for combining of participant responses to create an averaged rating, and thus, provides a more reliable estimation compared with an individual participant/expert [41] .
The systematic methodology employed to elicit patient and caregiver concepts followed by garnering of clinical expert consensus via a modified Delphi consensus panel, means that one can have reasonable confidence that the right concepts have been identified and are relevant to this specific population. The clinical experts believe these endpoints to be amenable to therapeutic interventions in DS. Additionally, the endpoint identification and mapping exercise ensured that outcome measures identified, comprehensively assess each of the five concepts considered important to DS. Although the instruments have been psychometrically validated in populations with health conditions [35, 37, 42, 43] including epilepsy [44, 45] , the reliability and validity (apart from content validity) of the endpoints in this population with DS specifically is unknown: therefore it will be necessary to assess the psychometric properties of the endpoints in a future clinical trial.
The study is not however without limitations. The interviews were conducted with caregivers and healthcare professionals involved in the care of children with DS in one country, France. Although it is likely that many of the concepts elicited would be generalizable to any caregiver of children with DS, there are country-specific differences (e.g., healthcare systems and societal preferences) which might influence how symptoms or impacts are perceived between countries. Future studies should be extended to other countries with different healthcare systems, to confirm cross-cultural relevance and equivalence of the elicited concepts. Furthermore, as no control group (for example patients with epilepsy without DS) was included in the study against which to compare concepts, there is the possibility that the concepts elicited may not be specific to DS. Additionally, the participant sample size might be perceived as limited; however, conceptual saturation was achieved for the overall sample and in each participant group, confirming that the sample size of caregivers and healthcare professionals was sufficient to address the research question. Specifically, all concepts had emerged before the final three interviews providing confidence that no additional concepts would have been elicited with more interviews. While the authors acknowledge the small sample size in the present study, effort was made to ensure that the demographic characteristics of the sample were diverse according to caregiver and patient age and gender and specialty of healthcare professional, ensuring that the sample was as representative as possible. However, the representativeness of these findings is planned to be assessed further in a larger sample in future work to conduct confirmatory interviews in additional countries.
An additional study limitation is that no adult patients with DS were included in the interviews. While adult patients will also likely have caregivers, the effect of DS is known to be most severe during childhood [46] . Therefore, by focusing on the younger age patients, we captured the greatest patient and caregiver impacts of DS. Although the study eligibility criteria included children from 2 to 18 years, no children under the age of five were recruited into the study. This is reflective of a number of factors including barriers to recruitment; it is unlikely that caregivers with very young children wanted to participate in a noninterventional study where there is no direct benefit to them or their child. Additionally, there is a delay in diagnosis of DS with some patients not receiving a diagnosis until the seventh year of life [47] .
Another potential limitation of this study was the fact that no caregivers were involved within the modified Delphi consensus panel. There may be some degree of bias associated with including only clinicians in the Delphi consensus panel, potentially leading to the potential composite endpoint being weighted more toward the clinician perspective. However, all the concepts rated by clinicians were derived from caregivers, therefore ensuring that the caregiver perspective was included. Additionally, clinicians were considered the most appropriate group to identify concepts that are clinically relevant, measurable, and likely to change with treatment.
Finally, the Delphi consensus panel technique has received criticism for not adhering to the rigorous scientific standards as other methodologies; however, it has been successfully employed in various fields including gaining consensus, program planning, needs assessment, and exploring underlying assumptions [48] . Given that DS is a rare disease, we feel this technique was best suited in confirming the clinical importance of the identified concepts. Scoring of such a composite endpoint would require to be validated in order to ensure validity and reliability of the composite endpoint.
Conclusions
This study identified patient-and caregiver-relevant impacts of DS, indicating that the experience of DS extends beyond the direct effect of seizures. These impacts formed a basis for developing a core set of endpoints, which could be used as a composite endpoint for use in clinical trials. Notably, if the benefits of therapeutic interventions are to be fully understood, it is important for a range of patient-and caregiver-relevant concepts to be captured as endpoints and assessed for change over time with treatment. Although a large number of relevant endpoints were identified in the qualitative interviews with patients and caregivers, a core set of five caregiver-and patient-relevant endpoints were deemed as clinically important, likely to demonstrate change in treatment over time and are measurable in a clinical trial setting. Future work is planned to use the five concepts identified to develop a strategy for measuring an endpoint using a composite score. This will incorporate the core concepts into one measure that can be implemented in clinical trials. These endpoints are to be included in a Phase III randomized placebo controlled trial in DS. Based upon the outcome of this trial and future studies, these endpoints may have the potential to be combined into a single composite endpoint for use in future trials in DS.
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